BioSpace News Archive

Business

Oncorus Pivots to Scale Up Manufacturing with New GMP Facility

Process development and quality control will begin in 2021, and full manufacturing capabilities at the 88,000-square-foot facility will be available in 2023.

January 7, 2021
·
2 min read
·
Mark Zipkin
Biopharma Investments Strong in the First Week of 2021

This week multiple companies have announced millions of investment dollars have flooded their coffers to advance research and development of multiple therapies. BioSpace is rounding up the announcements.

January 7, 2021
·
5 min read
·
Alex Keown
Business

BMS Kicks Off 2021 with $70 Million Collab for Next-Gen T Cell Cancer Therapies

ArsenalBio has entered into a multi-year discovery partnership with Bristol Myers Squibb to develop next-generation T cell therapies for solid tumors.

January 7, 2021
·
3 min read
·
Brandon May
Career Advice

Top 5 Things to Consider When Evaluating Master’s Programs

If you are certain that attending graduate school is the right move for you, it’s time to look into the specifics of various programs.

January 7, 2021
·
4 min read
·
Porschia Parker-Griffin
Drug Development

COVID-19 Vaccine News: Reactions, Efficacy, Dosing and More

Although yesterday’s media focus was on the riots at the U.S. Capitol, there was a fair amount of ongoing COVID-19 news. Here’s a look.

January 7, 2021
·
4 min read
·
Mark Terry
Could CRISPR Be the Key for Rapidly Aging Children?

NIH Director Francis Collins and David Liu of the Broad Institute have teamed up to conduct a study utilizing CRISPR, the genome-editing system, to see what they could do in terms of altering the aging process in mice.

January 7, 2021
·
2 min read
·
Krystle Vermes
Business

BioSpace Movers & Shakers, Jan. 8

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

January 7, 2021
·
8 min read
·
Alex Keown
Business

Fujifilm Diosynth Makes Another Big Splash In the U.S. Market

Morrisville, North Carolina, has reason to hope that it may be the beneficiary of Fujifilm’s next major investment, a $2 Billion USD large-scale cell culture manufacturing site which the company said will be located near one of its current facilities.

January 7, 2021
·
2 min read
·
Heather McKenzie
Business

COVID-19’s Effect on Biopharma M&As in 2020

Although they don’t necessarily agree on numbers, most reports indicate that 2020 was not a particularly good year for mergers and acquisitions in the biopharma industry.

January 7, 2021
·
4 min read
·
Mark Terry
Business

DBV Cuts 200 Jobs to Keep Fighting for Peanut Patch Approval

DBV announced official restructuring plan for keeping the company afloat.

January 7, 2021
·
1 min read
·
Kate Goodwin